Imaging for Assessment of Sudden Death Risk: Current Role and Future Prospects

Overview

Journal Europace

Publisher Oxford University Press

Specialties Cardiology & Vascular Diseases
Physiology

Date 2016 Apr 22

PMID 27098112

Citations 6

Authors

Takeki Suzuki

Saman Nazarian

Michael Jerosch-Herold

Sumeet S Chugh

Affiliations

Soon will be listed here.

Abstract

Sudden cardiac death (SCD) remains a major public health problem and there is an urgent need to maximize the impact of primary prevention using the implantable defibrillator. While implantable defibrillators are of utility for prevention of SCD, current methods of selecting candidates have significant shortcomings. Major advancements have occurred in the field of cardiac imaging, with significant potential to identify novel cardiac substrates for improved prediction. While assessment of the left ventricular ejection fraction remains the current major predictor, it is likely that several novel imaging markers will be incorporated into future risk stratification approaches. The goal of this review is to discuss the current status and future potential of cardiac imaging modalities to enhance risk stratification for SCD.

Citing Articles

Risk stratification for sudden cardiac death in patients with heart failure : Emerging role of imaging parameters.

Kammoun I, Bennour E, Laroussi L, Miled M, Sghaier A, Rahma K Herz. 2021; 46(6):550-557.

PMID: 33909114 DOI: 10.1007/s00059-021-05032-3.

Unlocking the PACS DICOM Domain for its Use in Clinical Research Data Warehouses.

Kaspar M, Liman L, Ertl M, Fette G, Seidlmayer L, Schreiber L J Digit Imaging. 2020; 33(4):1016-1025.

PMID: 32314069 PMC: 7522145. DOI: 10.1007/s10278-020-00334-0.

A clinical approach to arrhythmias revisited in 2018 : From ECG over noninvasive and invasive electrophysiology to advanced imaging.

Jordaens L Neth Heart J. 2018; 26(4):182-189.

PMID: 29450695 PMC: 5876171. DOI: 10.1007/s12471-018-1089-1.

Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.

Mehta P, Johnson B, Kenkre T, Eteiba W, Sharaf B, Pepine C J Am Heart Assoc. 2017; 6(8).

PMID: 28862961 PMC: 5586417. DOI: 10.1161/JAHA.117.005501.

Sudden cardiac death in 2017: Spotlight on prediction and prevention.

Chugh S Int J Cardiol. 2017; 237:2-5.

PMID: 28365183 PMC: 5476840. DOI: 10.1016/j.ijcard.2017.03.086.

References

Arora R, Ferrick K, Nakata T, Kaplan R, Rozengarten M, Latif F . I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003; 10(2):121-31. DOI: 10.1067/mnc.2003.2. View

Iles L, Pfluger H, Lefkovits L, Butler M, Kistler P, Kaye D . Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011; 57(7):821-8. DOI: 10.1016/j.jacc.2010.06.062. View

Anderson K, Walker R, Urie P, Ershler P, Lux R, Karwandee S . Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1993; 92(1):122-40. PMC: 293548. DOI: 10.1172/JCI116540. View

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley C . T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012; 14:26. PMC: 3405486. DOI: 10.1186/1532-429X-14-26. View

Chan R, Maron B, Olivotto I, Pencina M, Assenza G, Haas T . Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014; 130(6):484-95. DOI: 10.1161/CIRCULATIONAHA.113.007094. View

Flett A, Sado D, Quarta G, Mirabel M, Pellerin D, Herrey A . Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2012; 13(10):819-26. DOI: 10.1093/ehjci/jes102. View

Maron M, Appelbaum E, Harrigan C, Buros J, Gibson C, Hanna C . Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail. 2009; 1(3):184-91. DOI: 10.1161/CIRCHEARTFAILURE.108.768119. View

Majmudar M, Murthy V, Shah R, Kolli S, Mousavi N, Foster C . Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015; 16(8):900-9. PMC: 4592320. DOI: 10.1093/ehjci/jev012. View

Diller G, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A . Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot. Circulation. 2012; 125(20):2440-6. DOI: 10.1161/CIRCULATIONAHA.111.086983. View

10.

Piccini J, Horton J, Shaw L, Al-Khatib S, Lee K, Iskandrian A . Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circ Cardiovasc Imaging. 2009; 1(3):180-8. DOI: 10.1161/CIRCIMAGING.108.776484. View

11.

Aus dem Siepen F, Buss S, Messroghli D, Florian Andre , Lossnitzer D, Seitz S . T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2014; 16(2):210-6. DOI: 10.1093/ehjci/jeu183. View

12.

Pichler B, Judenhofer M, Catana C, Walton J, Kneilling M, Nutt R . Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med. 2006; 47(4):639-47. View

13.

Roes S, Borleffs C, van der Geest R, Westenberg J, Ajmone Marsan N, Kaandorp T . Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009; 2(3):183-90. DOI: 10.1161/CIRCIMAGING.108.826529. View

14.

Mintz G, Nissen S, Anderson W, Bailey S, Erbel R, Fitzgerald P . American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert.... J Am Coll Cardiol. 2001; 37(5):1478-92. DOI: 10.1016/s0735-1097(01)01175-5. View

15.

Bruder O, Wagner A, Jensen C, Schneider S, Ong P, Kispert E . Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010; 56(11):875-87. DOI: 10.1016/j.jacc.2010.05.007. View

16.

Coelho-Filho O, Shah R, Mitchell R, Neilan T, Moreno Jr H, Simonson B . Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013; 128(11):1225-33. PMC: 5308548. DOI: 10.1161/CIRCULATIONAHA.112.000438. View

17.

Gardner C, Tan H, Hull E, Lisauskas J, Sum S, Meese T . Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging. 2009; 1(5):638-48. DOI: 10.1016/j.jcmg.2008.06.001. View

18.

Parsai C, OHanlon R, Prasad S, Mohiaddin R . Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012; 14:54. PMC: 3436728. DOI: 10.1186/1532-429X-14-54. View

19.

Messroghli D, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K . Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping. Circ Cardiovasc Imaging. 2011; 4(6):636-40. DOI: 10.1161/CIRCIMAGING.111.966796. View

20.

Ji S, Travin M . Radionuclide imaging of cardiac autonomic innervation. J Nucl Cardiol. 2010; 17(4):655-66. DOI: 10.1007/s12350-010-9239-x. View